For patients with adenocarcinoma (adenoCA; wild-type [WT] EGFR) and squamous cell carcinoma (squCA), PORT with or without platinum-based CT may be a more suitable adjuvant treatment than EGFR TKI treatment. The gene discussed is EGFR; the disease is adenocarcinoma.